Literature DB >> 11298131

Increased Mycobacterium tuberculosis growth in HIV-1-infected human macrophages: role of tumour necrosis factor-alpha.

F G Imperiali1, A Zaninoni, L La Maestra, P Tarsia, F Blasi, W Barcellini.   

Abstract

Synergism between Mycobacterium tuberculosis (M. tuberculosis) and HIV-1 infections was demonstrated in several in vitro models and clinical studies. Here, we investigated their reciprocal effects on growth in chronically HIV-1-infected promonocytic U1 cells and in acutely infected monocyte-derived macrophages (MDM). Phagocytosis of M. tuberculosis induced HIV-1 expression in U1 cells, together with increased TNF-alpha production. M. tuberculosis growth, evaluated by competitive PCR, was greater in HIV-1-infected MDM compared to uninfected cells. M. tuberculosis phagocytosis induced greater TNF-alpha and IL-10 production in HIV-1-infected MDM than in uninfected cells. In uninfected MDM, addition of TNF-alpha and IFN-gamma decreased, whereas IL-10 increased M. tuberculosis growth. On the contrary, in HIV-1-infected MDM, addition of TNF-alpha and IFN-gamma increased, whereas IL-10 has no effect on M. tuberculosis growth. TNF-alpha seems to play a pivotal role in the enhanced M. tuberculosis growth observed in HIV-1-infected MDM, being unable to exert its physiological antimycobacterial activity. Here, for the first time we demonstrated an enhanced M. tuberculosis growth in HIV-1-infected MDM, in line with the observed clinical synergism between the two infections.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11298131      PMCID: PMC1906017          DOI: 10.1046/j.1365-2249.2001.01481.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  40 in total

1.  A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.

Authors:  P A Selwyn; D Hartel; V A Lewis; E E Schoenbaum; S H Vermund; R S Klein; A T Walker; G H Friedland
Journal:  N Engl J Med       Date:  1989-03-02       Impact factor: 91.245

2.  Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis.

Authors:  P F Barnes; S J Fong; P J Brennan; P E Twomey; A Mazumder; R L Modlin
Journal:  J Immunol       Date:  1990-07-01       Impact factor: 5.422

3.  Increased antimycobacterial immunity in interleukin-10-deficient mice.

Authors:  P J Murray; R A Young
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

4.  Secretion of interleukin-8 following phagocytosis of Mycobacterium tuberculosis by human monocyte cell lines.

Authors:  J S Friedland; D G Remick; R Shattock; G E Griffin
Journal:  Eur J Immunol       Date:  1992-06       Impact factor: 5.532

Review 5.  Biological properties of interleukin 10.

Authors:  M Howard; A O'Garra
Journal:  Immunol Today       Date:  1992-06

6.  An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms.

Authors:  C L Daley; P M Small; G F Schecter; G K Schoolnik; R A McAdam; W R Jacobs; P C Hopewell
Journal:  N Engl J Med       Date:  1992-01-23       Impact factor: 91.245

7.  Increase in tumor necrosis factor alpha- and interleukin-6-secreting cells in peripheral blood mononuclear cells from subjects infected with Mycobacterium tuberculosis.

Authors:  T Ogawa; H Uchida; Y Kusumoto; Y Mori; Y Yamamura; S Hamada
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

8.  Involvement of cytokines in determining resistance and acquired immunity in murine tuberculosis.

Authors:  M Denis
Journal:  J Leukoc Biol       Date:  1991-11       Impact factor: 4.962

9.  Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro.

Authors:  R S Kornbluth; P S Oh; J R Munis; P H Cleveland; D D Richman
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

10.  Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells.

Authors:  P Biswas; G Poli; A L Kinter; J S Justement; S K Stanley; W J Maury; P Bressler; J M Orenstein; A S Fauci
Journal:  J Exp Med       Date:  1992-09-01       Impact factor: 14.307

View more
  20 in total

1.  HIV-1 and the immune response to TB.

Authors:  Naomi F Walker; Graeme Meintjes; Robert J Wilkinson
Journal:  Future Virol       Date:  2013-01       Impact factor: 1.831

2.  Effects of in vitro HIV-1 infection on mycobacterial growth in peripheral blood monocyte-derived macrophages.

Authors:  Sharad Pathak; Tore Wentzel-Larsen; Birgitta Asjö
Journal:  Infect Immun       Date:  2010-07-12       Impact factor: 3.441

3.  Role of protease inhibitor 9 in survival and replication of Mycobacterium tuberculosis in mononuclear phagocytes from HIV-1-infected patients.

Authors:  Zahra Toossi; Mianda Wu; Shigou Liu; Christina S Hirsch; Jessica Walrath; Marieke van Ham; Richard F Silver
Journal:  AIDS       Date:  2014-03-13       Impact factor: 4.177

4.  Clinical and immune impact of Mycobacterium bovis BCG vaccination scarring.

Authors:  Janine Jason; Lennox K Archibald; Okey C Nwanyanwu; Peter N Kazembe; Julie A Chatt; Elizabeth Norton; Hamish Dobbie; William R Jarvis
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

5.  Alpha/beta interferon impairs the ability of human macrophages to control growth of Mycobacterium bovis BCG.

Authors:  Francine Bouchonnet; Neio Boechat; Marcel Bonay; Allan J Hance
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

6.  Inflammatory responses in blood samples of human immunodeficiency virus-infected patients with pulmonary infections.

Authors:  Natividad Benito; Asunción Moreno; Xavier Filella; José M Miró; Julià González; Tomás Pumarola; María Eugenia Valls; Montserrat Luna; Felipe García; Ana Rañó; Antoni Torres; José M Gatell
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

Review 7.  Treatment Options for HIV-Associated Tuberculosis.

Authors:  Philip Chukwuka Onyebujoh; Isabela Ribeiro; Christopher Curtis Whalen
Journal:  J Infect Dis       Date:  2007-08-15       Impact factor: 5.226

8.  Tuberculosis distorts the inhibitory impact of interleukin-10 in HIV infection.

Authors:  Shivan Chetty; Filippos Porichis; Pamla Govender; Jennifer Zupkosky; Musie Ghebremichael; Mona Pillay; Bruce D Walker; Thumbi Ndung'u; Daniel E Kaufmann; Victoria O Kasprowicz
Journal:  AIDS       Date:  2014-11-28       Impact factor: 4.177

Review 9.  A systematic review of the epidemiology, immunopathogenesis, diagnosis, and treatment of pleural TB in HIV-infected patients.

Authors:  A Aljohaney; K Amjadi; G G Alvarez
Journal:  Clin Dev Immunol       Date:  2012-03-14

Review 10.  Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy : pathogenesis, clinical manifestations and management.

Authors:  Devesh J Dhasmana; Keertan Dheda; Pernille Ravn; Robert J Wilkinson; Graeme Meintjes
Journal:  Drugs       Date:  2008       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.